News
Andrea Page-McCaw Named Associate Dean for Academic Affairs
Aug. 7, 2025—Julián Hillyer, Centennial Professor of Biological Sciences, and Andrea Page-McCaw, Stevenson Chair and professor of cell and developmental biology, have been named associate deans for academic affairs. Both served in their respective departments as director of graduate studies. As associate deans, Hillyer and Page-McCaw will oversee activities related to the curricula for graduate degree programs,...
New research points to cell subtypes that increase risk of diabetes
Jul. 25, 2025—If it has seemed like more people you know are developing diabetes, you are right. The diabetes epidemic is not called that for nothing: According to the American Diabetes Association, over 10 percent of the U.S. population—approximately 38.4 million people—had diabetes in 2021, and 1.2 million more people get diagnosed each year. Type 2 diabetes...
LAU and Coffey Receive John Oates Award
Jun. 6, 2025—During Vanderbilt University School of Medicine’s Spring Faculty Meeting and Awards Program, held May 30, Jeff Balser, MD, PhD, President and CEO of Vanderbilt University Medical Center and Dean of the School of Medicine, shared important updates. Recipients of the John A. Oates Award For Two or More Faculty Working Collaboratively or in a Multidisciplinary Manner...
DelGiorno Awarded American Cancer Society Research Scholar Award
May. 20, 2025—Kathleen DelGiorno was awarded an American Cancer Society Research Scholar Award. ($250k/year, 4 years). She was also able to get two of her students and her postdoc on training grants.
Lau and Coffey Receive $1 Million Grant
Oct. 2, 2024—The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a $1 million grant to support research at Vanderbilt aimed at dramatically expanding the efficacy of immunotherapy for colorectal cancer. Currently, only people with microsatellite-high colorectal cancer, which accounts for about 10% of patients, respond to immune checkpoint inhibitors, but Vanderbilt researchers have...
Alissa Weaver receives the Chancellor’s Award for Research at Fall Faculty Assembly
Aug. 22, 2024—Chancellor Daniel Diermeier, Provost C. Cybele Raver and Faculty Senate Chair Alissa Hare, who is assistant dean of the College of Arts and Science, presented awards at this year’s Fall Faculty Assembly to 10 faculty members who have made significant contributions through their scholarship, research or creative expression. Alissa Weaver, professor of cell and developmental...
Spraggins Named Director of Mass Spectrometry Research Center
Jul. 18, 2024—Jeffrey Spraggins, associate professor of cell and developmental biology, biochemistry, and chemistry, has been named director of the Mass Spectrometry Research Center. He succeeds Richard Caprioli, Stanford Moore Chair in Biochemistry, who established the MSRC in 1998 and who is retiring this summer. Spraggins is a leading scientist in spatial biology and imaging mass spectrometry—an untargeted molecular...
Weaver has hand in developing new tool that could lead to noninvasive “liquid biopsies”
Jul. 15, 2024—Researchers from the School of Medicine Basic Sciences recently developed an analytical tool that could lead to the use of “liquid biopsies” as a substitute for traditional biopsies for certain patients or diseases. The tool, called EV Fingerprinting, was the culmination of the dissertation work of Ariana von Lersner, a former graduate student and current postdoctoral...
Spraggins Among 2024 Faculty Fellows
Jun. 11, 2024—Thirteen outstanding faculty members from across the university have been selected for the 2024 cohort of Chancellor Faculty Fellows. This group is composed of highly accomplished, recently tenured faculty from a wide variety of disciplines and areas of expertise. “Through their transformative teaching and pathbreaking scholarship and research, Chancellor Faculty Fellows embody the Vanderbilt Way,” Chancellor...
Vivian Gama receives Seeding Success Grant
May. 31, 2024—On May 31st, Vivian Gama, Ph.D. was informed that her proposal “Mitochondrial fission defects drive disruptive neurogenesis in the rare disease EMPF1” was awarded a $120,000 Seeding Success Grant.